Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Long-Term Investments: 2014-2025

Historic Long-Term Investments for HUTCHMED (China) (HCM) over the last 3 years, with Jun 2025 value amounting to $3.6 million.

  • HUTCHMED (China)'s Long-Term Investments fell 95.47% to $3.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.6 million, marking a year-over-year decrease of 95.47%. This contributed to the annual value of $73.8 million for FY2022, which is 3.53% down from last year.
  • Per HUTCHMED (China)'s latest filing, its Long-Term Investments stood at $3.6 million for Q2 2025, which was down 95.47% from $80.5 million recorded in Q2 2024.
  • HUTCHMED (China)'s 5-year Long-Term Investments high stood at $133.8 million for Q1 2021, and its period low was $3.6 million during Q2 2025.
  • In the last 3 years, HUTCHMED (China)'s Long-Term Investments had a median value of $37.7 million in 2023 and averaged $40.6 million.
  • As far as peak fluctuations go, HUTCHMED (China)'s Long-Term Investments surged by 113.35% in 2024, and later plummeted by 95.47% in 2025.
  • Quarterly analysis of 5 years shows HUTCHMED (China)'s Long-Term Investments stood at $76.5 million in 2021, then fell by 3.53% to $73.8 million in 2022, then tumbled by 54.53% to $37.7 million in 2023, then surged by 113.35% to $80.5 million in 2024, then crashed by 95.47% to $3.6 million in 2025.
  • Its Long-Term Investments stands at $3.6 million for Q2 2025, versus $80.5 million for Q2 2024 and $37.7 million for Q2 2023.